The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
Abstract KRAS mutations have been reported as a reliable biomarker for epidermal growth factor receptor (EGFR) targeted therapy and are also associated with poor prognosis in colorectal cancer (CRC) patients. However, limitations of detecting KRAS mutations in tissues are obvious. KRAS mutations in...
Saved in:
Main Authors: | Wenli Xie, Li Xie, Xianrang Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1989 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
by: Thi Hue Hanh Nguyen, et al.
Published: (2025-01-01) -
Diagnostics of lung cancer by fragmentated blood circulating cell-free DNA based on machine learning methods
by: Ivan O. Meshkov, et al.
Published: (2025-01-01) -
Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
by: Fancheng Liu, et al.
Published: (2025-02-01) -
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01) -
Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA
by: Yuan Tian, et al.
Published: (2025-01-01)